Taiwan pharmaceutical exports rise 6.2% in 3rd-qtr 2011
Year-on-year exports by Taiwan's pharmaceutical industry for the third quarter of this year saw a rise of 6.2% to total New Taiwan $3.42 billion ($113 million) on the back of rising demand for western medicines, according to government report released over the weekend and reported by the Central News Agency (CNA).
The report from the Industry and Technology Intelligence Service (ITIS) noted that exports of Taiwan-made western medicines in the three month period rose 11.0% from a year earlier to NT$1.72 billion. It said exports of active pharmaceutical ingredients (APIs) from Taiwan edged up 1.3% to NT$1.58 billion, while the island's exports of Chinese medicines increased 9.1% NT$120 million.
Pharma imports grow 7.5%
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
More Features in Generics
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze